Amanote Research

Amanote Research

    RegisterSign In

Prevalence and Burden of Alpha-1 Antitrypsin Deficiency Among Hospitalized Copd Patients in the Us

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.1455
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
Date

May 1, 2015

Authors
C.M. BlanchetteJ. NooneD. RoyB.A. Van DorenE. ZacherleR. Howden
Publisher

Elsevier BV


Related search

The Prevalence of Alpha-1 Antitrypsin Deficiency in Ireland.

2009English

Alpha-1-Antitrypsin Deficiency

2020English

Alpha-1 Antitrypsin Deficiency

Journal of insurance medicine (New York, N.Y.)
Medicine
2015English

Alpha‐1‐Antitrypsin Deficiency

English

Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Alpha-1 Antitrypsin Deficiency in Patients With Chronic Hepatitis

Turkish Journal of Gastroenterology
Gastroenterology
2012English

Differences in Adjustment Between Individuals With Alpha-1 Antitrypsin Deficiency (AATD)-Associated COPD and Non-Aatd COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease
MedicinePulmonaryRespiratory Medicine
2013English

Alpha 1-Antitrypsin Deficiency and Liver Disease.

BMJ
1981English

Benefits Among Patients With Alpha-1 Antitrypsin Deficiency Enrolled in a Disease Management and Prevention Program

Chronic Obstructive Pulmonary Diseases
PulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy